Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional Trial.

about

Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional Trial.

Item

http://www.wikidata.org/entity/Q36359983

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Rupatadine in Established Trea ...... ive, Non-interventional Trial.

@ast

Rupatadine in Established Trea ...... ive, Non-interventional Trial.

@en

type

Item

label

Rupatadine in Established Trea ...... ive, Non-interventional Trial.

@ast

Rupatadine in Established Trea ...... ive, Non-interventional Trial.

@en

prefLabel

Rupatadine in Established Trea ...... ive, Non-interventional Trial.

@ast

Rupatadine in Established Trea ...... ive, Non-interventional Trial.

@en

P1476

Rupatadine in Established Trea ...... ive, Non-interventional Trial.

@en

P2093

Claudia Neumeister

http://www.w3.org/2001/XMLSchema#string

Iñaki Izquierdo

http://www.w3.org/2001/XMLSchema#string

Karsten Weller

http://www.w3.org/2001/XMLSchema#string

Marcus Maurer

http://www.w3.org/2001/XMLSchema#string

Rolf-Hasso Bödeker

http://www.w3.org/2001/XMLSchema#string

Ulrich Schwantes

http://www.w3.org/2001/XMLSchema#string

P2860

Rupatadine: pharmacological profile and its use in the treatment of allergic disorders

Rupatadine: a review of its use in the management of allergic disorders

Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)

Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.

No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines.

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.

Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis.

Rupatadine for the treatment of allergic rhinitis and urticaria.

Rupatadine for the treatment of urticaria.

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.

P2888

s13555-015-0089-y

P304

217-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13555-015-0089-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin Metz

P577

2015-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284358544

http://www.w3.org/2001/XMLSchema#string

P698

26591001

http://www.w3.org/2001/XMLSchema#string

P932

4674450

http://www.w3.org/2001/XMLSchema#string